Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Tumor-Agnostic 1Thoracic 1Plasma cell 1Gynecologic 1Genitourinary 1

Conditions

Cognitive Dysfunction 1Breast Neoplasms 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Trastuzumab 696Paclitaxel 679Cyclophosphamide 634Docetaxel 554Capecitabine 468Letrozole 407Carboplatin 393Fulvestrant 379Doxorubicin 330Tamoxifen 288pembrolizumab 272Anastrozole 252Epirubicin 249exemestane 238pertuzumab 229Bevacizumab 214Radiotherapy 213Gemcitabine 211Vinorelbine 188palbociclib 183Lapatinib 175130-nm albumin-bound paclitaxel 168Albumin-Bound Paclitaxel 156Exercise 147Magnetic Resonance Spectroscopy 145eribulin 144Taxes 134Fluorouracil 131Everolimus 118Cisplatin 118

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Tai Ji × Breast × Clear all
NCT04716920 2025-04-29

Tai Chi for Relieving Aromatase Inhibitor-Induced Arthralgia in Patients With Stage I-III Breast Cancer, the TaiChi4Joint Trial

Thomas Jefferson University

Phase NA Completed
39 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

NCT03196037 2019-03-07

Feasibility of an 8-week Tai Chi Chuan Intervention for Breast Cancer Survivors

UNC Lineberger Comprehensive Cancer Center

Phase NA Completed
4 enrolled
Breast

Breast Neoplasms, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡